Patent Reform Bill Would Allow Confirmatory Use Of Gene Tests Under Manager's Amendment
This article was originally published in The Pink Sheet Daily
Executive Summary
More than 30 amendments have been proposed to the bill in the House, including those to strike the conversion to a "first-to-file" patent system and eliminate PTO's fee-setting authority.
You may also be interested in...
House Patent Reform Bill Hits Roadblock As Appropriations Cmte. Objects To PTO Fee Provision
Stakeholders are furiously lobbying representatives to get them to retain a provision that would end PTO fee diversion to other government programs.
Myriad's BRCA Gene Patents Struck Down In Court; Are Biotech's Foundations Shaking?
Judge finds that isolated DNA is not different from that in the body and thus unpatentable; Myriad says its products are covered by other patents.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.